FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters
FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters
MedShadow ArticlesINVESTIGATING GENERICS: Two-Thirds of Americans Would Pay More for Safer DrugsLisa Jaycox
MedShadow ArticlesThe Truth About Supplements: Safety, Oversight, and the FDA’s RoleAmy Gragnolati, PharmD
MedShadow ArticlesINVESTIGATING GENERICS: Healthcare Providers Call Out Issues With Generic ADHD MedsEmma Yasinski
MedShadow ArticlesHow Much Vitamin D Do I Need? The Debate Behind Supplement GuidelinesKristel Tjandra and Gillian Dohrn
MedShadow ArticlesBlunted Before They Can Bloom: SSRIs and Sexual Side Effects in AdolescentsPeg Rosen
MedShadow ArticlesMedical Journals Have Flaws, But Government Oversight Isn’t the FixSuzanne B. Robotti
MedShadow ArticlesWhat Is Addyi? The Controversy Behind the Drug Nicknamed the ‘Female Viagra’Emma Yasinski and Sami Roberts
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: Tetracycline Antibiotics and Serious Skin Reactions, New Rinvoq Warnings for GCAKatie Rowley
